Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Walvax Biotechnology Co Ltd

+ Add to Watchlist

300142:CH

56.500 CNY 1.810 3.31%

As of 02:56:46 ET on 04/02/2015.

Snapshot for Walvax Biotechnology Co Ltd (300142)

Open: 55.950 Day's Range: 55.030 - 57.850 Volume: 6,827,310
Previous Close: 54.690 52wk Range: 30.320 - 57.850 1-Yr Rtn: +63.20%

Stock Chart for 300142

No chart data available.
  • 300142:CH 56.750
  • 1D
  • 1M
  • 1Y
54.690
Interactive 300142 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 300142

Current P/E Ratio (ttm) 91.5291
Estimated P/E(12/2015) 156.9444
Relative P/E vs. SZ399006 1.1761
Earnings Per Share (CNY) (ttm) 0.6173
Est. EPS (CNY) (12/2015) 0.3600
Est. PEG Ratio -
Market Cap (M CNY) 13,221.00
Shares Outstanding (M) 234.00
30 Day Average Volume 2,893,812
Price/Book (mrq) 4.5803
Price/Sale (ttm) 18.5572
Dividend Indicated Gross Yield 0.09%
Cash Dividend (CNY) 0.0500
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 300142

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 300142

Walvax Biotechnology Company Limited develops, manufactures and sells bio-pharmaceutical vaccination products. The Company's products include haemophilus influenzae type b conjugate vaccine and meningococcal group A,C bivalent polysaccharide conjugate vaccine.

Li YunchunChairman/PresidentChen ErjiaVice Chairman
Huang ZhenVice PresidentYang ZhongdongVice President
More Company Profile & Key Executives for 300142

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil